Lycopodium (ASX:LYL) is expected to steadily convert its opportunity pipeline to support modest earnings growth in the near-term, according to a Thursday Euroz Hartleys note.
The company on Thursday said it expects fiscal year 2026 revenue in the range of AU$390 million to AU$410 million, up from the actual result of AU$339.6 million last year.
The research firm expects the company to report fiscal year 2026 underlying diluted earnings per share of AU$1.058 with a revenue of AU$396.7 million.
Euroz Hartleys maintained its buy rating on Lycopodium and raised its price target to AU$14.85 from AU$13.92.